Darby John Patrick's Form 4 filing
Encompass Health CorpEHC · filed Apr 30, 2025
- Accession no.
- 0001127602-25-012784
- Filed
- Apr 30, 2025
- Trade date
- Apr 29, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.15M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Darby John PatrickCIK 0001664699 | Officer (EVP, Gen Counsel & Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Encompass Health Common Stock | MOption exerciseAcquired | +10,000 | $35.06 | +$350,600 | 89,710 | Direct | |
| Apr 29, 2025 | Encompass Health Common Stock | SSaleDisposed | −10,000 | $114.79F1 | −$1,147,900 | 79,710 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Encompass Health Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 4,858 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.69 to $115.26, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Referenced by the price of 1 transaction in Table I.